...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Sparks Therapeutics Gene Therapy Deal

 Golfyeti,

Yes eye popping numbers for that Spark deal. What a week for adeno-associated virus (AAV) biotech in the news! In addition to Spark, Voyager and Abbvie's were in the news this week for their deal to use Voyager's AAV-mediated vectorized antibody approach. That's pre-clinical, but still very cool stuff.

BearDownAZ

Share
New Message
Please login to post a reply